dihydroxyphenylalanine has been researched along with Behavior Disorders in 66 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Excerpt | Relevance | Reference |
---|
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 63 (95.45) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (1.52) | 29.6817 |
2010's | 2 (3.03) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pretze, M | 1 |
Wängler, C | 1 |
Wängler, B | 1 |
Capuron, L | 1 |
Pagnoni, G | 1 |
Drake, DF | 1 |
Woolwine, BJ | 1 |
Spivey, JR | 1 |
Crowe, RJ | 1 |
Votaw, JR | 1 |
Goodman, MM | 1 |
Miller, AH | 1 |
TRUITT, EB | 1 |
EBERSBERGER, EM | 1 |
SCHULTE, W | 1 |
Gorman, JM | 1 |
Sabelli, HC | 1 |
Mosnaim, AD | 1 |
Vazquez, AJ | 1 |
Giardina, WJ | 1 |
Borison, RL | 1 |
Pedemonte, WA | 1 |
Nemeroff, CB | 1 |
Loosen, PT | 1 |
Bissette, G | 1 |
Manberg, PJ | 1 |
Wilson, IC | 1 |
Lipton, MA | 1 |
Prange, AJ | 1 |
Gehlen, W | 1 |
Gonce, M | 1 |
Barbeau, A | 2 |
Campbell, KM | 1 |
Wade, D | 1 |
Ross, LW | 1 |
Meyer, GG | 1 |
Hunter, KR | 1 |
Stern, GM | 2 |
Sharkey, J | 1 |
Tan, BK | 1 |
Leijnse-Ybema, HJ | 1 |
v d Brand, HJ | 1 |
Botez, MI | 1 |
Calne, DB | 2 |
Spiers, AS | 1 |
Laurence, DR | 1 |
Hällström, T | 1 |
Persson, T | 2 |
Jenkins, RB | 1 |
Groh, RH | 1 |
Sacks, OW | 2 |
Kohl, M | 1 |
Bird, MT | 1 |
Paulson, GW | 1 |
Schnur, JA | 2 |
Chase, TN | 1 |
Brody, JA | 2 |
Constantinidis, J | 1 |
Van Woert, MH | 1 |
Ambani, LM | 1 |
Levine, RJ | 1 |
Vinar, O | 1 |
Wyatt, RJ | 1 |
Reid, JL | 1 |
Mones, RJ | 1 |
Julsrud, OJ | 1 |
Horvath, TB | 1 |
Meares, RA | 1 |
Boudin, G | 2 |
Pépin, B | 2 |
Guillard, A | 3 |
Fabiani, JM | 1 |
Haguenau, M | 1 |
Völler, GW | 1 |
Muschard, F | 1 |
Murphy, DL | 1 |
Rinne, UK | 2 |
Stancer, HC | 1 |
Sathananthan, G | 1 |
Angrist, BM | 1 |
Gershon, S | 1 |
Vogt, M | 1 |
Rosati, G | 1 |
Agnetti, V | 1 |
Mura, F | 1 |
Granieri, E | 1 |
Presthus, J | 1 |
Holmsen, R | 1 |
Celesia, GG | 1 |
Wanamaker, WM | 1 |
Lhermitte, F | 2 |
Degos, CF | 1 |
Kohl, MS | 1 |
Messeloff, CR | 1 |
Schwartz, WF | 1 |
Cole, JO | 1 |
Shapiro, SK | 1 |
Lehmann, J | 1 |
Almici, GM | 1 |
Sbarbaro, V | 1 |
Rysánek, K | 1 |
Kaeser, HE | 1 |
Ferel, D | 1 |
Wurmser, P | 1 |
Knopp, W | 1 |
Castaigne, P | 1 |
Beck, H | 1 |
Marteau, R | 1 |
Rondot, P | 1 |
Raphy, B | 1 |
Sonninen, V | 1 |
Siirtola, T | 1 |
Klawans, HL | 2 |
McKendall, RR | 1 |
Newkirk, TA | 1 |
Magee, KR | 1 |
Chase, RN | 1 |
Gordon, EK | 1 |
Longo, V | 1 |
Kemali, D | 1 |
Pacini, A | 1 |
Bertolino, A | 1 |
Lamura, G | 1 |
Goodwin, FK | 1 |
Inanaga, K | 1 |
Oshima, M | 1 |
Tachibana, H | 1 |
Nakamura, K | 1 |
Koketsu, K | 1 |
Ginath, Y | 1 |
Lavy, S | 1 |
Abramsky, O | 1 |
Carmon, A | 1 |
Garvin, JS | 1 |
Bonduelle, M | 1 |
Wålinder, J | 1 |
Jelsma, F | 1 |
Roth, R | 1 |
Ross, P | 1 |
Davis, J | 1 |
12 reviews available for dihydroxyphenylalanine and Behavior Disorders
Article | Year |
---|---|
6-[18F]fluoro-L-DOPA: a well-established neurotracer with expanding application spectrum and strongly improved radiosyntheses.
Topics: Brain Neoplasms; Dihydroxyphenylalanine; Humans; Mental Disorders; Movement Disorders; Radioactive T | 2014 |
Biochemical plasticity of synaptic transmission: a critical review of Dale's Principle.
Topics: 5-Hydroxytryptophan; Animals; Brain; Carbidopa; Deamination; Dihydroxyphenylalanine; Evoked Potentia | 1976 |
Pharmaco-behavioral effects of hypothalamic peptides in animals and man: focus on thyrotropin-releasing hormone and neurotensin.
Topics: Animals; Behavior, Animal; Body Temperature; Brain; Dihydroxyphenylalanine; Drug Synergism; Humans; | 1978 |
[Iatrogenic damage possibilities in the drug therapy of neurologic and psychiatric diseases].
Topics: Amantadine; Anticonvulsants; Barbiturates; Benzodiazepines; Carbamazepine; Central Nervous System Di | 1977 |
[The current treatment of Parkinson's disease].
Topics: Amantadine; Antidepressive Agents, Tricyclic; Dihydroxyphenylalanine; Drug Combinations; Histamine A | 1976 |
[Clinical psychopharmacology in 1971].
Topics: Amphetamine; Antidepressive Agents; Antiparkinson Agents; Chemical Phenomena; Chemistry; Chlorpromaz | 1972 |
Antiparkinsonian drugs: pharmacological and therapeutic aspects.
Topics: Acetylcholine; Adrenergic beta-Antagonists; Amantadine; Amphetamine; Antiparkinson Agents; Apomorphi | 1972 |
Mental effects of L-dopa.
Topics: Affective Symptoms; Behavior; Cognition; Dihydroxyphenylalanine; Dopamine; Humans; Learning; Memory; | 1973 |
Recent advances in the treatment of Parkinsonism with drugs.
Topics: Amantadine; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Arrhythmias, Cardiac; Blood-Brain | 1972 |
Psychopharmacology. Yesterday, today and tomorrow: a point of view.
Topics: Affective Symptoms; Amitriptyline; Antidepressive Agents; Canada; Carbonates; Depression; Dihydroxyp | 1973 |
Functional aspects of the role of catecholamines in the central nervous system.
Topics: Animals; Brain; Catecholamines; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Epinephrine; Huma | 1973 |
[Relation of monoamines to mental disorders].
Topics: Amines; Animals; Bipolar Disorder; Catecholamines; Central Nervous System; Depression; Dihydroxyphen | 1970 |
8 trials available for dihydroxyphenylalanine and Behavior Disorders
Article | Year |
---|---|
L-dopa in idiopathic parkinsonism.
Topics: Clinical Trials as Topic; Dihydroxyphenylalanine; Humans; Hypotension, Orthostatic; Mental Disorders | 1969 |
Clinical effects of para-chlorophenylalanine in Parkinson's disease.
Topics: Aged; Benztropine; Brain; Clinical Trials as Topic; Depression; Dihydroxyphenylalanine; Evaluation S | 1972 |
The serotonin-catecholamine-dream bicycle: a clinical study.
Topics: 5-Hydroxytryptophan; Aged; Brain; Brain Chemistry; Catecholamines; Clinical Trials as Topic; Dihydro | 1972 |
Response threshold to levodopa in psychiatric patients.
Topics: Adult; Brain Chemistry; Clinical Trials as Topic; Cognition Disorders; Dihydroxyphenylalanine; Dopam | 1973 |
[Treatment of Parkinsonic syndrome with levo-Dopa. Case reports].
Topics: Arteriosclerosis; Clinical Trials as Topic; Dihydroxyphenylalanine; Drug Evaluation; Female; Humans; | 1974 |
Psychiatric changes in patients treated with levodopa. I. The clinical experiment.
Topics: Activities of Daily Living; Adjustment Disorders; Aged; Amitriptyline; Clinical Trials as Topic; Dia | 1970 |
[Treatment of Parkinson's disease with L-dopa. 77 cases].
Topics: Adult; Age Factors; Aged; Cardiovascular Diseases; Clinical Trials as Topic; Dihydroxyphenylalanine; | 1970 |
L-Dopa treatment in Parkinson's Disease.
Topics: Age Factors; Anorexia Nervosa; Cardiovascular Diseases; Clinical Trials as Topic; Dihydroxyphenylala | 1970 |
46 other studies available for dihydroxyphenylalanine and Behavior Disorders
Article | Year |
---|---|
Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration.
Topics: Adult; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Hepatitis C, Chronic; Humans; Inte | 2012 |
Decarboxylase inhibitors affect convulsion thresholds to hexafluorodiethyl ether.
Topics: Amines; Animals; Brain; Carboxy-Lyases; Dihydroxyphenylalanine; Ether; Lyases; Mental Disorders; Mic | 1962 |
[PSYCHIATRIC UNIVERSITY CLINIC AND PSYCHIATRIC STATE HOSPITAL].
Topics: Aging; Brain Diseases; Dihydroxyphenylalanine; Germany; Germany, West; Hospitals, Psychiatric; Hospi | 1964 |
More to movement disorders than motion.
Topics: Basal Ganglia; Deep Brain Stimulation; Dihydroxyphenylalanine; Humans; Mental Disorders; Movement Di | 2006 |
[Cerebral amines].
Topics: Amines; Animals; Brain; Dihydroxyphenylalanine; Haplorhini; Humans; Mental Disorders; Mice; Neurons; | 1976 |
Pigmentation and musculoskeletal abnormalities in an aged state hospital population.
Topics: Adult; Aged; Bone Diseases; Dihydroxyphenylalanine; Female; Humans; Male; Melanins; Melatonin; Menta | 1977 |
Levodopa in postencephalitic parkinsonism.
Topics: Dihydroxyphenylalanine; Humans; Mental Disorders; Movement Disorders; Parkinson Disease, Postencepha | 1970 |
L-dopa. II.
Topics: Anorexia Nervosa; Cardiac Complexes, Premature; Dihydroxyphenylalanine; Drug Synergism; Humans; Hypo | 1970 |
Levodopa in Huntington's chorea.
Topics: Chlorpromazine; Dihydroxyphenylalanine; Female; Humans; Huntington Disease; Mental Disorders; Middle | 1972 |
Letter: Long term mental changes in levodopa-treated patients.
Topics: Dihydroxyphenylalanine; Follow-Up Studies; Humans; Intelligence Tests; Mental Disorders; Mental Proc | 1973 |
L-dopa and non-emission of semen.
Topics: Adult; Dihydroxyphenylalanine; Ejaculation; Female; Humans; Male; Mental Disorders; Middle Aged; Sem | 1970 |
Mental symptoms in Parkinsonian patients treated with L-dopa.
Topics: Aged; Behavior; Depression; Dihydroxyphenylalanine; Dreams; Female; Humans; Imipramine; Male; Memory | 1970 |
L-dopa and oculogyric crises.
Topics: Catalepsy; Dihydroxyphenylalanine; Encephalitis, Arbovirus; Eye; Humans; Mental Disorders | 1970 |
Early onset rigid Huntington's disease.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Diagnosis, Differential; Dihydroxyphenylalanine; E | 1970 |
Parkinsonism-dementia of Guam: treatment with L-dopa.
Topics: Adult; Dementia; Dihydroxyphenylalanine; Drug Eruptions; Female; Humans; Hydroxyindoleacetic Acid; H | 1971 |
[Monoamines and choreic syndromes].
Topics: Amines; Butyrophenones; Chorea; Diazepam; Dihydroxyphenylalanine; Dopamine; Ganglia; Globus Pallidus | 1972 |
Parkinson's disease treated with L-dopa. Three-year follow-up report.
Topics: Dihydroxyphenylalanine; Follow-Up Studies; Humans; Mental Disorders; Movement Disorders; Nausea; Par | 1972 |
Treatment failures with L-dopa in Parkinsonism.
Topics: Adult; Aged; Dihydroxyphenylalanine; Female; Gastrointestinal Diseases; Humans; Intracranial Arterio | 1972 |
The relevance of the neurophysiological concepts of excitation and inhibition to clinical psychiatry.
Topics: Acoustic Stimulation; Adolescent; Adult; Aged; Alcohol Amnestic Disorder; Anxiety; Arousal; Dihydrox | 1973 |
[Indications and results of monoamine treatment in parkinsonian syndromes].
Topics: Aged; Arrhythmias, Cardiac; Benserazide; Carboxy-Lyases; Dihydroxyphenylalanine; Drug Combinations; | 1972 |
Efficacy of and possible differences in tolerance to L-dopa tablets with different rates of release of the active substance.
Topics: Administration, Oral; Arrhythmias, Cardiac; Dihydroxyphenylalanine; Drug Tolerance; Feeding and Eati | 1974 |
[Long-term treatment of Parkinsonism with L-dopa].
Topics: Adult; Aged; Anorexia Nervosa; Dihydroxyphenylalanine; Female; Humans; Long-Term Care; Male; Mental | 1972 |
Psychiatric disturbances in Parkinson's disease.
Topics: Adult; Aged; Barbiturates; Cognition Disorders; Depression; Dihydroxyphenylalanine; Female; Follow-U | 1972 |
[Treatment of Parkinson syndromes with L-Dopa and the association of L-Dopa and a decarboxylase inhibitor].
Topics: Aged; Arrhythmias, Cardiac; Carboxy-Lyases; Dihydroxyphenylalanine; Drug Synergism; Female; Gastroin | 1972 |
[Drug therapy of Parkinson's diseases].
Topics: Amantadine; Dihydroxyphenylalanine; Gastrointestinal Diseases; Humans; Hypotension, Orthostatic; Men | 1972 |
Effects of levodopa in Parkinsonian patients with dementia.
Topics: Aged; Delirium; Dihydroxyphenylalanine; Evaluation Studies as Topic; Female; Humans; Male; Mental Di | 1972 |
The impact of scientific models on clinical psychopharmacology: a psychiatrist's view.
Topics: Antidepressive Agents; Anxiety Disorders; Attitude of Health Personnel; Behavior Therapy; Brain; Con | 1972 |
Hypersexual behavior complicating levodopa (I-dopa) therapy.
Topics: Aged; Dihydroxyphenylalanine; Erectile Dysfunction; Humans; Male; Mental Disorders; Parkinson Diseas | 1973 |
Levodopa and related drugs.
Topics: Amantadine; Apomorphine; Dihydroxyphenylalanine; Humans; Hydrazines; Hypotension; Mental Disorders; | 1973 |
Psychiatric complications of medical drugs.
Topics: Adrenal Cortex Hormones; Digitalis Glycosides; Dihydroxyphenylalanine; Drug-Related Side Effects and | 1973 |
Tryptophan malabsorption in levodopa-treated parkinsonian patients. Effect of tryptophan on mental disturbances.
Topics: Aged; Brain; Dementia; Depression, Chemical; Dihydroxyphenylalanine; Female; Humans; Hydroxyindoleac | 1973 |
[Case reports of some mental disorders in parkinsonian patients treated with L-dopa].
Topics: Aged; Anxiety Disorders; Cognition Disorders; Depression; Dihydroxyphenylalanine; Female; Hallucinat | 1974 |
Editorial: Mental changes in Parkinsonism.
Topics: Brain; Dihydroxyphenylalanine; Humans; Mental Disorders; Parkinson Disease | 1974 |
[Treatment of Parkinson's syndrome with L-dopa].
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Antihypertensive Agents; Barbiturates; | 1970 |
Observations on the effect of levodopa on tardive lingual-facial-buccal dyskinesia.
Topics: Aged; Chlorpromazine; Dihydroxyphenylalanine; Dopamine; Facial Muscles; Female; Haloperidol; Humans; | 1971 |
Treatment of parkinsonism with levo-dopa: results in 302 cases.
Topics: Aged; Dihydroxyphenylalanine; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Hypotens | 1971 |
Parkinsonism-dementia and amyotrophic lateral sclerosis of Guam. Effect of probenecid on monoamine catabolite levels in cerebrospinal fluid.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Dihydroxyphenylalanine; Dopamine; Female; Humans; Hydrox | 1971 |
[Evaluation in clinical trials of some drug associations. (L-dopa, neuroleptics and lithium carbonate)].
Topics: Basal Ganglia Diseases; Dihydroxyphenylalanine; Extrapyramidal Tracts; Humans; Lithium; Mental Disor | 1971 |
Behavioral effects of l-dopa in man.
Topics: Adult; Aged; Cerebral Cortex; Cognition Disorders; Confusion; Delirium; Delusions; Depression; Dihyd | 1971 |
Three cases of schizophrenia treated with L-dopa.
Topics: Adult; Autistic Disorder; Delusions; Dihydroxyphenylalanine; Drug Synergism; Female; Hallucinations; | 1971 |
Mental complications of L-dopa therapy in Parkinson's patients.
Topics: Adult; Aged; Dihydroxyphenylalanine; Drug Antagonism; Female; Humans; Male; Mental Disorders; Middle | 1971 |
Treatment of parkinsonism with L-dopa (study of 105 patients).
Topics: Adolescent; Adult; Age Factors; Aged; Alkaline Phosphatase; Anorexia Nervosa; Aspartate Aminotransfe | 1969 |
[Psychic manifestations during treatment of Parkinson's disease with L-dopa].
Topics: Dihydroxyphenylalanine; Humans; Mental Disorders; Parkinson Disease; Parkinson Disease, Postencephal | 1970 |
Levodopa.
Topics: Age Factors; Dihydroxyphenylalanine; Drug and Narcotic Control; Humans; Intelligence; Intelligence T | 1970 |
L-DOPA in the treatment of depressive symptoms.
Topics: Adult; Depression; Dihydroxyphenylalanine; Female; Humans; Male; Mental Disorders; Middle Aged; Remi | 1971 |
Preliminary observations on L-dopa in the treatment of Parkinson's disease.
Topics: Administration, Oral; Adult; Age Factors; Aged; Aspartate Aminotransferases; Dihydroxyphenylalanine; | 1971 |